Company news
Cutia Therapeutics news in 2026
Cutia Therapeutics's news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 5, 2026
Next Day Disclosure Return
October 26, 2026
Voluntary announcement - latest update on the cooperation with rejuven
October 20, 2026
Next Day Disclosure Return
October 5, 2026
Next Day Disclosure Return
October 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Voluntary announcement - share repurchase program under the share repurchase mandate
September 30, 2026
List of directors and their roles and functions
September 30, 2026
Change of executive director
September 30, 2026
2026 Interim Report
September 24, 2026
Voluntary announcement - CU-40102 (topical finasteride spray) obtained marketing approval by the macao pharmaceutical administration bureau
September 20, 2026
Poll results of the annual general meeting held on 26 June 2026
June 26, 2026